Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care

1Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the benefits and harms of psychedelic/entactogen-assisted therapy compared to placebo or active comparators (e.g. antidepressants) for treatment of anxiety, depression, and existential distress in adult palliative care.

Cite

CITATION STYLE

APA

Schipper, S., Nigam, K., Piechotta, V., Ljuslin, M., Beaussant, Y., Schwarzer, G., & Boehlke, C. (2022). Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care. Cochrane Database of Systematic Reviews, 2022(11). https://doi.org/10.1002/14651858.CD015383

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free